Aduhelm (aducanumab), first new Alzheimer’s drug in 20 years.
8 Giugno 2021
Aduhelm (aducanumab) has been approved by the FDA for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated
